Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CHF | -1.86% | -4.48% | -8.77% |
04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.77% | 114M | |
+7.46% | 71.94B | |
+11.16% | 9.27B | |
-11.55% | 5.13B | |
+48.05% | 4.66B | |
+5.09% | 3.97B | |
-14.74% | 2.55B | |
+20.17% | 2.41B | |
-24.89% | 2.36B | |
+21.45% | 2.21B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Gets Positive Opinion From European Medicines Agency's Committee for Duchenne MD Drug